These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 31280139

  • 1. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM, Moon JY, Ryu JY, Cho SK.
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [Abstract] [Full Text] [Related]

  • 2. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells.
    Moon JY, Manh Hung LV, Unno T, Cho SK.
    Nutrients; 2018 Nov 26; 10(12):. PubMed ID: 30486290
    [Abstract] [Full Text] [Related]

  • 3. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
    Groenendijk FH, Mellema WW, van der Burg E, Schut E, Hauptmann M, Horlings HM, Willems SM, van den Heuvel MM, Jonkers J, Smit EF, Bernards R.
    Int J Cancer; 2015 Mar 15; 136(6):1434-44. PubMed ID: 25080865
    [Abstract] [Full Text] [Related]

  • 4. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC, Yeh HH, Huang WL, Yan JJ, Lai WW, Su WP, Chen HH, Su WC.
    Am J Respir Cell Mol Biol; 2013 Aug 15; 49(2):241-50. PubMed ID: 23526220
    [Abstract] [Full Text] [Related]

  • 5. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
    Kenessey I, Kói K, Horváth O, Cserepes M, Molnár D, Izsák V, Dobos J, Hegedűs B, Tóvári J, Tímár J.
    Oncotarget; 2016 Nov 29; 7(48):79503-79514. PubMed ID: 27780929
    [Abstract] [Full Text] [Related]

  • 6. Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.
    Moro M, Caiola E, Ganzinelli M, Zulato E, Rulli E, Marabese M, Centonze G, Busico A, Pastorino U, de Braud FG, Vernieri C, Simbolo M, Bria E, Scarpa A, Indraccolo S, Broggini M, Sozzi G, Garassino MC.
    J Thorac Oncol; 2018 Nov 29; 13(11):1692-1704. PubMed ID: 30149143
    [Abstract] [Full Text] [Related]

  • 7. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.
    Storozhuk Y, Hopmans SN, Sanli T, Barron C, Tsiani E, Cutz JC, Pond G, Wright J, Singh G, Tsakiridis T.
    Br J Cancer; 2013 May 28; 108(10):2021-32. PubMed ID: 23632475
    [Abstract] [Full Text] [Related]

  • 8. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q, Liu Z, Jiang L, Liu M, Ma J, Yang C, Han L, Nan K, Liang X.
    Mol Med Rep; 2016 Mar 28; 13(3):2590-6. PubMed ID: 26847819
    [Abstract] [Full Text] [Related]

  • 9. Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line.
    Manh Hung LV, Song YW, Cho SK.
    Mar Drugs; 2018 Mar 27; 16(4):. PubMed ID: 29584673
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents.
    Klingbeil O, Lesche R, Gelato KA, Haendler B, Lejeune P.
    Cell Death Dis; 2016 Sep 08; 7(9):e2365. PubMed ID: 27607580
    [Abstract] [Full Text] [Related]

  • 11. BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
    Ku BM, Jho EH, Bae YH, Sun JM, Ahn JS, Park K, Ahn MJ.
    Invest New Drugs; 2015 Feb 08; 33(1):12-21. PubMed ID: 25342139
    [Abstract] [Full Text] [Related]

  • 12. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J, Cheng J, Yu B, Duan C, Peng J.
    Med Sci Monit; 2018 Apr 10; 24():2126-2133. PubMed ID: 29632297
    [Abstract] [Full Text] [Related]

  • 13. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
    Luo M, Mo J, Yu Q, Zhou S, Ning R, Zhang Y, Su C, Wang H, Cui J.
    Biomed Pharmacother; 2018 Oct 10; 106():593-598. PubMed ID: 29990847
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer.
    Shen X, Zhao Y, Liu G, Zhou HL, Fan J, Zhang L, Li YL, Wang Y, Liang J, Xu ZX.
    Life Sci; 2020 Sep 01; 256():117923. PubMed ID: 32522567
    [Abstract] [Full Text] [Related]

  • 15. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI, Hong JY, Lee HJ, Bae SY, Jung C, Park HJ, Lee SK.
    PLoS One; 2015 Sep 01; 10(12):e0144368. PubMed ID: 26656173
    [Abstract] [Full Text] [Related]

  • 16. 6'-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK/miR-299-5p/ATF2 axis.
    Gao J, Song L, Xia H, Peng L, Wen Z.
    Respir Res; 2020 Feb 03; 21(1):39. PubMed ID: 32014006
    [Abstract] [Full Text] [Related]

  • 17. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W, Ping W, Tian Y, Zou W, Liu J, Zu Y.
    Cell Physiol Biochem; 2018 Feb 03; 51(5):2160-2171. PubMed ID: 30522099
    [Abstract] [Full Text] [Related]

  • 18. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
    Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F.
    Oncotarget; 2016 Jan 26; 7(4):4265-78. PubMed ID: 26673006
    [Abstract] [Full Text] [Related]

  • 19. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y, Ma J, Zhang J, He L, Gong J, Long C.
    Oncol Rep; 2017 Jan 26; 37(1):313-322. PubMed ID: 28004121
    [Abstract] [Full Text] [Related]

  • 20. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J, Liu JH, Liu H, Liao XZ, Chen Y, Lin MG, Gu YY, Liu TL, Wang DM, Ge H, Mo SL.
    BMC Cancer; 2016 Nov 18; 16(1):899. PubMed ID: 27863471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.